Kidney health biotech Renasant Bio emerges with $54M to follow in Vertex’s footsteps

A Berkeley, CA-based biotech that wants to replicate Vertex’s success with corrector and potentiator medicines has raised a $54.5 million seed round. The funding, disclosed Thursday morning, will help Renasant Bio get closer to the ...